Investor Presentaiton
Growth Strategy
Little Green Pharma has a track record of sales growth with a clear
pathway to increasing margins and driving significant revenue
growth in Australia and offshore markets
1
Patient
acquisition in
Australia
2
Why these are strategically important:
Clear pathway to
international sales
3
Product and drug
delivery
innovations
Sales in Australia demonstrate
market validity and generate
immediate cash flow to support
development of international
pathways
>
Early-mover commercial volumes in
international markets the primary
mechanism to secure and grow
offshore market share
Focus on developing unique
delivery systems for patients in the
future to solve real patient
problems and differentiate LGP
little
green
pharmaView entire presentation